Navigation Links
Fatherhood Tied to Higher Prostate Cancer Risk
Date:1/7/2008

Findings from large study show a trend, but reasons aren't clear

MONDAY, Jan. 7 (HealthDay News) -- Men who father children may be at higher risk of prostate cancer compared to those who forego the life experience, a Danish study suggests.

The large-scale study looked at all men born in Denmark between 1935 and 1988. It found that childless men had a 17 percent lower incidence of prostate cancer than fathers did.

The reasons why remain unclear.

"It is not possible from the current data to point out what factors associated with childlessness, whether biologic, environmental, social or behavioral, were responsible for the observed reduction in prostate cancer risk," wrote researchers at the Statens Serum Institut, in Copenhagen.

The study is published in the Jan. 7 online edition of Cancer, and will appear in the journal's Feb. 15 print edition.

The findings echo those of a prior Scandinavian study, published in 2005, which looked at more than 48,800 cases of prostate cancer. That report also found a 17 percent lower incidence of prostate cancer among childless men.

In neither of the two studies did the gender of the children fathered affect the man's risk of prostate cancer. However, one large-scale study conducted several years ago in Israel found that the malignancy was 40 percent more common among men with no sons.

Dr. Susan Harlap, now a professor of epidemiology at New York University, led that Israeli study. She said the differing results reflect the complex factors, genetic and otherwise, that underlie prostate cancer risk throughout the world.

"The incidence of prostate cancer is different in Israeli Jews than in northwestern Europeans," Harlap said. "It may be a different disease, and there may be a different set of causes. We do know there are genetic causes of prostate cancer, and there could be different sets of genes in Israeli Jews than in nort
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Farming, Fatherhood Hallmarks of Men Who Live to 100
2. Fatherhood linked to prostate cancer risk
3. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
4. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
5. Hushed Genes Might Mean Higher Lung Cancer Risk
6. Higher death rates in kidney patients with newly recognized disease
7. Vulnerable groups are not at higher risk of physician-assisted death
8. Study Determines Breast-Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms
9. In birds, expecting to mate leads to higher fertilization rates
10. COPD rates, higher than expected in China, will continue to grow
11. Caesarean births pose higher risks for mother and baby
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fatherhood Tied to Higher Prostate Cancer Risk
Fatherhood Tied to Higher Prostate Cancer Risk
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 62585 1Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 62585 2Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 62585 3Senate Approval of Mikulski Amendment Further Opens Health Care Bill to Massive Federal Funding of Abortion 62581 1Senate Approval of Mikulski Amendment Further Opens Health Care Bill to Massive Federal Funding of Abortion 62581 2Ginger Prices Could Skyrocket on H1N1 Fears 62576 1Ginger Prices Could Skyrocket on H1N1 Fears 62576 2